IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells

Background Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 14; no. 1; p. 118
Main Authors Johnson, Jill R, Nishioka, Michiyoshi, Chakir, Jamila, Risse, Paul-André, Almaghlouth, Ibrahim, Bazarbashi, Ahmad N, Plante, Sophie, Martin, James G, Eidelman, David, Hamid, Qutayba
Format Journal Article
LanguageEnglish
Published London BioMed Central 01.11.2013
Subjects
Online AccessGet full text
ISSN1465-993X
1465-9921
1465-993X
DOI10.1186/1465-9921-14-118

Cover

Abstract Background Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects. Methods Primary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22. Results Primary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics. Conclusion The impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells.
AbstractList Background Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects. Methods Primary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22. Results Primary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics. Conclusion The impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells.
Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects. Primary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22. Primary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics. The impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells.
Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects.BACKGROUNDAllergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects.Primary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22.METHODSPrimary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22.Primary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics.RESULTSPrimary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics.The impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells.CONCLUSIONThe impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells.
ArticleNumber 118
Author Plante, Sophie
Johnson, Jill R
Eidelman, David
Hamid, Qutayba
Chakir, Jamila
Risse, Paul-André
Almaghlouth, Ibrahim
Martin, James G
Bazarbashi, Ahmad N
Nishioka, Michiyoshi
AuthorAffiliation 1 Meakins-Christie Laboratories, McGill University, 3626 St. Urbain Street, Montréal, QC H2X 2P2, Canada
2 Centre de recherche de l'institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada
AuthorAffiliation_xml – name: 1 Meakins-Christie Laboratories, McGill University, 3626 St. Urbain Street, Montréal, QC H2X 2P2, Canada
– name: 2 Centre de recherche de l'institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada
Author_xml – sequence: 1
  givenname: Jill R
  surname: Johnson
  fullname: Johnson, Jill R
  organization: Meakins-Christie Laboratories, McGill University
– sequence: 2
  givenname: Michiyoshi
  surname: Nishioka
  fullname: Nishioka, Michiyoshi
  organization: Meakins-Christie Laboratories, McGill University
– sequence: 3
  givenname: Jamila
  surname: Chakir
  fullname: Chakir, Jamila
  organization: Centre de recherche de l'institut universitaire de cardiologie et de pneumologie de Québec
– sequence: 4
  givenname: Paul-André
  surname: Risse
  fullname: Risse, Paul-André
  organization: Meakins-Christie Laboratories, McGill University
– sequence: 5
  givenname: Ibrahim
  surname: Almaghlouth
  fullname: Almaghlouth, Ibrahim
  organization: Meakins-Christie Laboratories, McGill University
– sequence: 6
  givenname: Ahmad N
  surname: Bazarbashi
  fullname: Bazarbashi, Ahmad N
  organization: Meakins-Christie Laboratories, McGill University
– sequence: 7
  givenname: Sophie
  surname: Plante
  fullname: Plante, Sophie
  organization: Centre de recherche de l'institut universitaire de cardiologie et de pneumologie de Québec
– sequence: 8
  givenname: James G
  surname: Martin
  fullname: Martin, James G
  organization: Meakins-Christie Laboratories, McGill University
– sequence: 9
  givenname: David
  surname: Eidelman
  fullname: Eidelman, David
  organization: Meakins-Christie Laboratories, McGill University
– sequence: 10
  givenname: Qutayba
  surname: Hamid
  fullname: Hamid, Qutayba
  email: qutayba.hamid@mcgill.ca
  organization: Meakins-Christie Laboratories, McGill University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24283210$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1rGzEQFSElX-29p6JjL0pH8mpXewmEkKQBQy8J5CZk7ThW2JVcSVvw38oPyW-qFjvBLbSnGUbvzdN7c0oOffBIyGcO55yr-huvasnaVnDGK1YmB-RkN5o9Hu71x-Q0pWcA3qhGHpFjUQk1ExxOSLibMyGoDT5HtxgzJpoDvb-9Ya8vnA3YOZOxo7h2eYW9M32ZJfR2tRlMT3M0PrnsgqfOU5PyajDZWbqIoUAKeo9ILfZ9-kg-LE2f8NOunpGHm-v7q-9s_uP27upyzmzFW8VM17a1ABCopLRNB9iBkqVKjgtlbb3slDSVlTNZjDStsGCFRIC24wIlzM7IxXbvelwUFxaLP9PrdXSDiRsdjNN_vni30k_hl654U0NblwVfdwti-DliynpwabJgPIYx6ZJtJQFATVpf9rXeRd5SLgDYAmwMKUVcvkM46OmQ0zapp0OWbpoUSv0XxbpspqTLb13_PyLfElPR8E8Y9XMYoy9Z_5vzGwZ1sn4
CitedBy_id crossref_primary_10_1080_17476348_2016_1174580
crossref_primary_10_3389_fimmu_2021_601842
crossref_primary_10_1002_jcp_26284
crossref_primary_10_1016_j_pedneo_2017_11_020
crossref_primary_10_3892_ol_2019_10972
crossref_primary_10_3390_biom11020310
crossref_primary_10_1186_s12931_017_0563_4
crossref_primary_10_1183_16000617_0112_2021
crossref_primary_10_1016_j_jaci_2016_09_022
crossref_primary_10_1007_s10753_015_0123_3
crossref_primary_10_1016_j_clim_2024_110228
crossref_primary_10_1080_21645515_2018_1509649
crossref_primary_10_1002_eji_201646723
crossref_primary_10_1007_s11033_020_05439_x
crossref_primary_10_1038_aps_2014_91
crossref_primary_10_1097_ACI_0000000000000701
crossref_primary_10_1371_journal_pone_0122372
crossref_primary_10_1038_s42003_021_01797_9
crossref_primary_10_1016_j_yexcr_2018_12_017
crossref_primary_10_1002_ptr_7774
crossref_primary_10_3892_mmr_2014_2941
crossref_primary_10_1093_jpp_rgae064
crossref_primary_10_1002_1878_0261_12598
crossref_primary_10_1371_journal_pone_0184386
crossref_primary_10_1186_s12860_021_00356_8
crossref_primary_10_1016_j_ebiom_2018_06_032
crossref_primary_10_1371_journal_pone_0149180
crossref_primary_10_3389_fcimb_2021_739874
crossref_primary_10_1007_s10753_022_01621_4
crossref_primary_10_1177_1535370215597194
crossref_primary_10_3390_jcm5070063
crossref_primary_10_1111_cea_12712
crossref_primary_10_1007_s40629_015_0039_3
crossref_primary_10_1016_j_cellsig_2021_110123
crossref_primary_10_1186_s12931_018_0834_8
crossref_primary_10_5812_ijp_114153
crossref_primary_10_12659_MSM_899955
crossref_primary_10_1186_s12931_014_0146_6
crossref_primary_10_1016_j_alit_2018_10_002
crossref_primary_10_1111_cei_13337
crossref_primary_10_1007_s10753_023_01847_w
crossref_primary_10_1080_02770903_2022_2155186
crossref_primary_10_3389_fimmu_2022_1040442
crossref_primary_10_1513_AnnalsATS_201407_304AW
crossref_primary_10_1134_S2079086418050055
crossref_primary_10_1016_j_taap_2022_116044
crossref_primary_10_1002_jcp_24832
crossref_primary_10_1165_rcmb_2016_0307TR
crossref_primary_10_3892_mmr_2015_4518
crossref_primary_10_1089_jir_2021_0222
crossref_primary_10_1186_s12890_021_01698_x
crossref_primary_10_3389_falgy_2022_806391
crossref_primary_10_1007_s00018_020_03693_7
crossref_primary_10_3389_falgy_2020_628381
crossref_primary_10_1111_all_15889
crossref_primary_10_1016_j_jss_2015_02_062
crossref_primary_10_15369_sujms_28_101
crossref_primary_10_1038_s41598_024_66068_z
crossref_primary_10_3346_jkms_2024_39_e266
crossref_primary_10_1016_j_cytogfr_2014_04_005
crossref_primary_10_1016_j_jaci_2017_04_005
crossref_primary_10_1007_s15007_015_0750_x
crossref_primary_10_1016_j_smim_2019_101346
crossref_primary_10_1111_cea_12451
crossref_primary_10_1099_jmm_0_000581
Cites_doi 10.1038/nri2870
10.1159/000250438
10.1186/1465-9921-10-100
10.1038/ni.1892
10.1080/08820130903062756
10.1172/JCI200320530
10.1074/jbc.M204204200
10.1016/j.immuni.2012.05.028
10.1164/rccm.200811-1730OC
10.1016/j.jaci.2009.02.024
10.1371/journal.pone.0016175
10.1016/j.jaci.2005.06.011
10.1016/S0140-6736(00)03496-6
10.1007/s00281-009-0189-9
10.1093/intimm/dxr001
10.1136/thx.24.2.176
10.1096/fj.12-208033
10.1186/1465-9921-7-135
10.1016/j.jaci.2010.12.1117
10.1172/JCI39104
10.1016/j.jaci.2007.11.023
10.1038/ncb1905
10.1002/eji.200838655
10.1016/j.cyto.2010.02.003
10.1164/rccm.200909-1448OC
10.1056/NEJMoa0805435
10.1164/rccm.200209-1030OC
10.1007/s10875-010-9368-7
10.1164/ajrccm.162.6.ats9-00
10.1186/1755-1536-3-2
10.1016/j.devcel.2008.05.009
10.1164/ajrccm/148.5.1220
10.1067/mai.2001.115624
10.1183/09031936.00138707
10.1038/mi.2012.76
10.1165/rcmb.2008-0449OC
10.1016/j.jaci.2012.09.036
10.1159/000318854
10.1165/ajrcmb.27.2.4779
10.1007/s11926-007-0075-1
10.1074/jbc.M007837200
10.1165/ajrcmb.15.3.8810634
10.1165/rcmb.2010-0027TR
ContentType Journal Article
Copyright Johnson et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2013 Johnson et al.; licensee BioMed Central Ltd. 2013 Johnson et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: Johnson et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright © 2013 Johnson et al.; licensee BioMed Central Ltd. 2013 Johnson et al.; licensee BioMed Central Ltd.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1186/1465-9921-14-118
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1465-993X
EndPage 118
ExternalDocumentID PMC4176096
24283210
10_1186_1465_9921_14_118
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Canadian Institutes of Health Research
GroupedDBID ---
0R~
29P
2WC
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M1P
M48
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c4198-ad9962002e855c7d0ed0857d051eb8cc6fd85a4c535832792c0c25e009d12e503
IEDL.DBID M48
ISSN 1465-993X
1465-9921
IngestDate Thu Aug 21 14:17:09 EDT 2025
Thu Sep 04 17:43:42 EDT 2025
Thu Apr 03 07:04:44 EDT 2025
Tue Jul 01 02:43:04 EDT 2025
Thu Apr 24 22:51:15 EDT 2025
Sat Sep 06 07:29:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Airway Smooth Muscle
Severe Asthmatic
Allergic Asthma
Bronchial Epithelial Cell
Airway Epithelial Cell
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4198-ad9962002e855c7d0ed0857d051eb8cc6fd85a4c535832792c0c25e009d12e503
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1465-9921-14-118
PMID 24283210
PQID 1464500080
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4176096
proquest_miscellaneous_1464500080
pubmed_primary_24283210
crossref_primary_10_1186_1465_9921_14_118
crossref_citationtrail_10_1186_1465_9921_14_118
springer_journals_10_1186_1465_9921_14_118
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20131101
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 20131101
  day: 1
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Respiratory research
PublicationTitleAbbrev Respir Res
PublicationTitleAlternate Respir Res
PublicationYear 2013
Publisher BioMed Central
Publisher_xml – name: BioMed Central
References Y Zhao (1425_CR6) 2010; 151
F Goulet (1425_CR26) 1996; 15
SV Kotenko (1425_CR40) 2001; 276
B Schnyder (1425_CR30) 2010; 50
MS Dunnill (1425_CR16) 1969; 24
T Vincent (1425_CR43) 2009; 11
D Lejeune (1425_CR41) 2002; 277
LC Borish (1425_CR7) 2001; 107
C Blaschitz (1425_CR12) 2010; 30
AM Hanash (1425_CR36) 2012; 37
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions (1425_CR25) 2000; 162
Y Chang (1425_CR28) 2012; 26
AM Doerner (1425_CR33) 2009; 10
A Rosendahl (1425_CR42) 2002; 27
CK Wong (1425_CR5) 2009; 38
D Pennino (1425_CR35) 2013; 131
W Al-Ramli (1425_CR3) 2009; 123
LA Zenewicz (1425_CR14) 2011; 23
DM Bullens (1425_CR4) 2006; 7
L Benayoun (1425_CR18) 2003; 167
R Kalluri (1425_CR20) 2003; 112
C Pepe (1425_CR19) 2005; 116
TL Hackett (1425_CR32) 2009; 180
HY Kim (1425_CR1) 2010; 11
J Zhao (1425_CR23) 2012; 6
E Lubberts (1425_CR11) 2010; 32
J Yang (1425_CR44) 2008; 14
FJ Rodriguez (1425_CR37) 1826; 2012
J Corren (1425_CR8) 2010; 181
ME Darveau (1425_CR27) 2008; 121
S Kamitani (1425_CR38) 2011; 155
CM Lloyd (1425_CR2) 2010; 10
ED Bateman (1425_CR24) 2008; 31
K Kuwano (1425_CR17) 1993; 148
JR Johnson (1425_CR21) 2011; 6
Y Chang (1425_CR29) 2011; 127
E Fitch (1425_CR13) 2007; 9
MJ Leckie (1425_CR9) 2000; 356
LA Zenewicz (1425_CR15) 2008; 38
J Camara (1425_CR34) 2010; 3
P Nair (1425_CR10) 2009; 360
R Halwani (1425_CR31) 2011; 44
R Kalluri (1425_CR22) 2009; 119
IH Heijink (1425_CR39) 2010; 42
References_xml – volume: 10
  start-page: 838
  year: 2010
  ident: 1425_CR2
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2870
– volume: 151
  start-page: 297
  year: 2010
  ident: 1425_CR6
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000250438
– volume: 10
  start-page: 100
  year: 2009
  ident: 1425_CR33
  publication-title: Respir Res
  doi: 10.1186/1465-9921-10-100
– volume: 11
  start-page: 577
  year: 2010
  ident: 1425_CR1
  publication-title: Nat Immunol
  doi: 10.1038/ni.1892
– volume: 38
  start-page: 652
  year: 2009
  ident: 1425_CR5
  publication-title: Immunol Invest
  doi: 10.1080/08820130903062756
– volume: 112
  start-page: 1776
  year: 2003
  ident: 1425_CR20
  publication-title: J Clin Investig
  doi: 10.1172/JCI200320530
– volume: 277
  start-page: 33676
  year: 2002
  ident: 1425_CR41
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M204204200
– volume: 37
  start-page: 339
  year: 2012
  ident: 1425_CR36
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.05.028
– volume: 180
  start-page: 122
  year: 2009
  ident: 1425_CR32
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200811-1730OC
– volume: 123
  start-page: 1185
  year: 2009
  ident: 1425_CR3
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2009.02.024
– volume: 6
  start-page: e16175
  year: 2011
  ident: 1425_CR21
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0016175
– volume: 2012
  start-page: 23
  year: 1826
  ident: 1425_CR37
  publication-title: Biochim Biophys Acta
– volume: 116
  start-page: 544
  year: 2005
  ident: 1425_CR19
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2005.06.011
– volume: 356
  start-page: 2144
  year: 2000
  ident: 1425_CR9
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)03496-6
– volume: 32
  start-page: 43
  year: 2010
  ident: 1425_CR11
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-009-0189-9
– volume: 23
  start-page: 159
  year: 2011
  ident: 1425_CR14
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxr001
– volume: 24
  start-page: 176
  year: 1969
  ident: 1425_CR16
  publication-title: Thorax
  doi: 10.1136/thx.24.2.176
– volume: 26
  start-page: 5152
  year: 2012
  ident: 1425_CR28
  publication-title: FASEB J
  doi: 10.1096/fj.12-208033
– volume: 7
  start-page: 135
  year: 2006
  ident: 1425_CR4
  publication-title: Respir Res
  doi: 10.1186/1465-9921-7-135
– volume: 127
  start-page: 1046
  year: 2011
  ident: 1425_CR29
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.12.1117
– volume: 119
  start-page: 1420
  year: 2009
  ident: 1425_CR22
  publication-title: J Clin Investig
  doi: 10.1172/JCI39104
– volume: 121
  start-page: 692
  year: 2008
  ident: 1425_CR27
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2007.11.023
– volume: 11
  start-page: 943
  year: 2009
  ident: 1425_CR43
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1905
– volume: 38
  start-page: 3265
  year: 2008
  ident: 1425_CR15
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200838655
– volume: 50
  start-page: 220
  year: 2010
  ident: 1425_CR30
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2010.02.003
– volume: 181
  start-page: 788
  year: 2010
  ident: 1425_CR8
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200909-1448OC
– volume: 360
  start-page: 985
  year: 2009
  ident: 1425_CR10
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0805435
– volume: 167
  start-page: 1360
  year: 2003
  ident: 1425_CR18
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200209-1030OC
– volume: 30
  start-page: 196
  year: 2010
  ident: 1425_CR12
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-010-9368-7
– volume: 162
  start-page: 2341
  year: 2000
  ident: 1425_CR25
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.162.6.ats9-00
– volume: 3
  start-page: 2
  year: 2010
  ident: 1425_CR34
  publication-title: Fibrogenesis & Tissue Repair
  doi: 10.1186/1755-1536-3-2
– volume: 14
  start-page: 818
  year: 2008
  ident: 1425_CR44
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2008.05.009
– volume: 148
  start-page: 1220
  year: 1993
  ident: 1425_CR17
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/148.5.1220
– volume: 107
  start-page: 963
  year: 2001
  ident: 1425_CR7
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2001.115624
– volume: 31
  start-page: 143
  year: 2008
  ident: 1425_CR24
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00138707
– volume: 6
  start-page: 335
  issue: 2
  year: 2012
  ident: 1425_CR23
  publication-title: Mucosal Immunol
  doi: 10.1038/mi.2012.76
– volume: 42
  start-page: 69
  year: 2010
  ident: 1425_CR39
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2008-0449OC
– volume: 131
  start-page: 562
  year: 2013
  ident: 1425_CR35
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2012.09.036
– volume: 155
  start-page: 119
  year: 2011
  ident: 1425_CR38
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000318854
– volume: 27
  start-page: 160
  year: 2002
  ident: 1425_CR42
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/ajrcmb.27.2.4779
– volume: 9
  start-page: 461
  year: 2007
  ident: 1425_CR13
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-007-0075-1
– volume: 276
  start-page: 2725
  year: 2001
  ident: 1425_CR40
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M007837200
– volume: 15
  start-page: 312
  year: 1996
  ident: 1425_CR26
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/ajrcmb.15.3.8810634
– volume: 44
  start-page: 127
  year: 2011
  ident: 1425_CR31
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2010-0027TR
SSID ssj0017875
Score 2.324845
Snippet Background Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction....
Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction....
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 118
SubjectTerms Adolescent
Adult
Aged
Asthma - metabolism
Asthma - pathology
Asthma - physiopathology
Biopsy
Bronchi - drug effects
Bronchi - pathology
Bronchi - physiopathology
Cadherins - metabolism
Case-Control Studies
Cells, Cultured
Epithelial Cells - drug effects
Epithelial Cells - pathology
Epithelial Cells - physiology
Epithelial-Mesenchymal Transition - drug effects
Epithelial-Mesenchymal Transition - physiology
Female
Humans
In Vitro Techniques
Interleukin-22
Interleukins - pharmacology
Interleukins - physiology
Male
Medicine
Medicine & Public Health
Middle Aged
Mucin 5AC - metabolism
Phenotype
Pneumology/Respiratory System
RNA, Messenger - metabolism
Severity of Illness Index
Transforming Growth Factor beta1 - pharmacology
Transforming Growth Factor beta1 - physiology
Young Adult
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwELYoSFUvCOhreclIvYBkETt-5YhW3QKCnkDiFtmOV4u0TRAJB_4WP4TfxIw3u2JLW6m3yBlbSeabeMbzIuRbZk3MnQlM6yxHAyWwIkTHZOF4sGPnxwZzhy9_6tNreX6jbvrzDsyFee2_51YfgyArVhSCMy4ZjLwjawp-u4jloR4u_AUAOzV3Qv5h1vKm80aTfBsQ-ZtXNG02ow2y3muJ9GTG1k2yEust8v6y94N_JM3ZBROCpjhzbFgVW9o19OrHiD0_cZayQUCTpPEOMy6mADEYawGPk8dfsGyH-1MK1aK3NXVtN0l1W6m_b2oMfZ6-mkjxZL_9RK5H36-Gp6xvncCC5IVlrgI7BuMvolUqmCqLFZayr0AEo7ch6HFllZNB5QpE2hQiZEGoCApXxUVUWf6ZrNZNHb8SqmXwQhjvpTfSVsY77nleOczRNdHoATmef9sy9HXFsb3FtEz2hdVoXagSuQFXODIgh4sZd7OaGv-gPZizqwTg4zu7OjYPLVJKlTTeAfkyY99iNSFTBya4Y5YYuyDAotrLd-rbSSquLbnRYNYNyNEcAmUv1e1fH3L7f4h3yAeBLTVSPuMuWe3uH-IeKDad30-YfgE3gvFl
  priority: 102
  providerName: Springer Nature
Title IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells
URI https://link.springer.com/article/10.1186/1465-9921-14-118
https://www.ncbi.nlm.nih.gov/pubmed/24283210
https://www.proquest.com/docview/1464500080
https://pubmed.ncbi.nlm.nih.gov/PMC4176096
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfYJiFe0MbXwkZlJF5AMsuHP5IHhLpqZVRsQrBKfYtsx1UnlWQ0mcT-Lf4Q_qbduUlH2cZToosdOb47-S539ztC3oSpcolWlkkZJuigWJZZpxnPdGTTqTZThbXDJ6fyeMxHEzG5KY9uN7C-07XDflLjxfz9r59XH0HhP3iFT-UBKLtgWRZHLOIMKBtky0eLMJGP38QUQDRFF6i8YxbCAnPfuCdcP6NuGZ638yf_CaL6s2m4TR63RiXtL6Vghzxw5RPy8KQNmz8l1ecvLI6pT0vH_laupk1Fzz4N2Z_fEfPFI2B4UneBBRpzkEig1SC-s6sf8NoGjzOf2UXPS6rrZuZhXqlZVCVmSs__mkgxEFA_I-Ph0dngmLWdFpjlUZYyXYDbg-kaLhXCqiJ0BSLfF6CxzqTWymmRCs2tSARskMpiG9pYOLDPiih2Ikyek82yKt0uoZJbE8fKGG4UTwtldGSipNBY0quckgE56PY2ty0MOXbDmOfeHUklOiMiR8bAHVIC8nY142IJwfGfsa87duWgJ_jNunTVZY0jufAGckBeLNm3elvH94CoNcauBiAG9_qT8nzmsbh5pCR4gQF514lA3snwvYt8ee8C9sijGNtt-FrHfbLZLC7dKzB6GtMjG2qiemSr3x99H8H18Oj06zegDuSg538k9Ly0XwNsQQH_
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDBa2Duh2GfZe9qoK9NICQi1ZLx-HYFnaJT2lQG-GJCtIgcwuavewv7Ufst80UnGCZu0G7GbIlGCLJESK5EdCDjJrYu5MYFpnOToogRUhOiYLx4OdOz83WDs8PdPjc3l6oS76-w6shbkdv-dWH4MiK1YUgjMuGYw8JI8wboko-UM93MQLQOzUOgh5z6ztQ-eOJXk3IfKPqGg6bEbPyNPeSqSfV2x9Th7E-gXZnfZx8JekOZkwIWjKM8eGVbGlXUNnX0fs10_OUjUIWJI0XmHFxRJEDMZakMfFj--wbIfnU0rVopc1dW23SLit1F83NaY-L29NpHiz374i56Mvs-GY9a0TWIDtscxV4Mdg_kW0SgVTZbFCKPsKVDB6G4KeV1Y5GVSuQKVNIUIWhIpgcFVcRJXlr8lO3dTxLaFaBi-E8V56I21lvOOe55XDGl0TjR6Q4_XelqHHFcf2Fssy-RdWo3ehSuQGPOHIgBxuZlytMDX-Qbu_ZlcJgo__7OrY3LRIKVWyeAfkzYp9m9WETB2Y4I3ZYuyGAEG1t9_Ul4sEri250eDWDcjRWgTKXqvbv37ku_8h3iOPx7PppJycnH17T54IbK-Rahs_kJ3u-iZ-BCOn85-SfP8Guhb0VA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZtAqGXkL43fanQSwtiLVkvH5e222SbhEITyM3otWxgay-xc8jfyg_pb4pGtpdu0xZ6M9JI2J4ZNKOZ-Qahd5lWITfKESmzHBwURwoXDOGFoU7PjZ0rqB0-PpEHZ3x2Ls77C7dmyHYfQpJdTQOgNFXteOXnnYprOY7qLUhRMEooJ3HkPtrWoiii87U9mcy-z9ZxhCiOYghO_mHd5mF0x8K8myj5W7Q0HULTPbTbW4940rH7IboXqkdo57iPjz9G9eERYQyn_HNoZBUa3Nb49MuU_LyhJFWJRAsThxVUYiyj6MWxJsrp4vpH3LaFcyulcOGLCpumXSQ8V2wv6wpSope_LMRw4988QWfTz6cfD0jfUoE4TgtNjI_-DeRlBC2EUz4LHiDufVTNYLVzcu61MNyJXERVVwVzmWMiREPMUxZElj9FW1VdhecIS-4sY8pabhXXXllDLc29gdpdFZQcofHwb0vX441D24tlmfwOLcHrECVwIz7ByAi9X69YdVgb_6B9O7CrjAoB32yqUF81QMlFsoRH6FnHvvVujKfOTHFGbTB2TQBg25sz1cUigW5zqmR090bowyACZa_tzV9fcv9_iN-gnW-fpuXR4cnXF-gBg64bqeTxJdpqL6_Cq2j7tPZ1L-C3Xan-Eg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-22+contributes+to+TGF-%CE%B21-mediated+epithelial-mesenchymal+transition+in+asthmatic+bronchial+epithelial+cells&rft.jtitle=Respiratory+research&rft.au=Johnson%2C+Jill+R&rft.au=Nishioka%2C+Michiyoshi&rft.au=Chakir%2C+Jamila&rft.au=Risse%2C+Paul-Andr%C3%A9&rft.date=2013-11-01&rft.eissn=1465-993X&rft.volume=14&rft.spage=118&rft_id=info:doi/10.1186%2F1465-9921-14-118&rft_id=info%3Apmid%2F24283210&rft.externalDocID=24283210
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon